Evidence map›Paper›PMID 39271483›Full record

ReviewZeitschrift fur Rheumatologie2024

[News on the imaging of large vessel vasculitis].

Valentin S Schäfer, Simon M Petzinna, Wolfgang A Schmidt

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Zeitschrift fur Rheumatologie, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. [RMD open · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. [News on the imaging of large vessel vasculitis].Zeitschrift fur Rheumatologie · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Valentin S SchäferSektion Rheumatologie und Klinische Immunologie, Medizinische Klinik III, Universitätsklinikum Bonn, Venusberg-Campus 1, 53127, Bonn, Deutschland. valentin.schaefer@ukbonn.de.ORCID http://orcid.org/0000-0002-6591-5936
Simon M PetzinnaSektion Rheumatologie und Klinische Immunologie, Medizinische Klinik III, Universitätsklinikum Bonn, Venusberg-Campus 1, 53127, Bonn, Deutschland.
Wolfgang A SchmidtAbteilung für Rheumatologie und Klinische Immunologie, Immanuel Krankenhaus Berlin, Standort Berlin-Buch, Berlin, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Large vessel vasculitis, including giant cell arteritis (GCA) and Takayasu arteritis (TAK), are autoimmune diseases primarily affecting the aorta and its branches. GCA is the most common primary vasculitis. Inflammatory changes in the vessel walls can cause serious complications such as amaurosis, stroke, and aortic dissection and rupture. Imaging techniques have become an integral part for the diagnosis and monitoring of large vessel vasculitis, allowing for effective disease monitoring. GCA and TAK exhibit similar patterns of vascular distribution. However, the temporal arteries are never involved in TAK, and axillary arteritis occurs more frequently in GCA. In most centers, ultrasound of the temporal and axillary arteries has replaced temporal artery biopsy as the primary diagnostic tool for GCA. In addition to ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), and [

Indexed as

Giant Cell ArteritisTakayasu ArteritisDiagnosis, DifferentialEvidence-Based MedicineHumansImage EnhancementMagnetic Resonance ImagingPositron Emission Tomography Computed TomographySensitivity and SpecificityUltrasonographyGiant cell arteritisMagnetic resonance imagingPolymyalgia rheumaticaPositron emission tomographyTakayasu arteritis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.